This new major conference will encompass the very best of basic, translational, and clinical research in immunology, inflammation and immunotherapies for cancer, including immuno-oncology (IO) drugs, inflammatory modulators, vaccines, and cellular therapies. The cutting-edge AACR IO 2025 program will appeal to a wide audience of basic scientists, translational researchers, clinical investigators, regulators, industry, investors, and lay press. A mix of keynote lectures, major symposia, spotlight sessions, educational sessions, special sessions, and poster sessions with exhibits will cover the spectrum of the IO field – including late-breaking clinical trials sessions highlighting new agents and IO combinations, and the results of practice-changing clinical trials.

ABSTRACT CATEGORIES

• Adaptive immunity in tumors
• Adoptive cell therapy
• Antibodies
• Antigens
• Car t
• Cellular therapy
• Combination immunotherapies
• Cytokines
• Endogenous antitumor immunity
• Epigenetic regulation of tumor immunity
• Immune checkpoints
• Immune mechanisms
• Immune monitoring
• …